Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 10/20 | 0.37 |
| ▸ | CA1 | P00915 | 9/20 | 0.37 |
| ▸ | CA5A | P35218 | 5/20 | 0.37 |
| ▸ | CA7 | P43166 | 5/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 6/20 | 0.35 |
| ▸ | CA9 | Q16790 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6904683 | 0.77 | PTGS1 (0.41) | CA2CA1CA5ACA7HPGD | |
| SCHEMBL6911268 | 0.76 | CA2 (0.39) | CA2CA1CA5ACA7CA5B | |
| SCHEMBL6908277 | 0.70 | PTGS1 (0.41) | CA2CA1CA5ACA7CA12 | |
| SCHEMBL6906116 | 0.69 | PTGS1 (0.36) | CA2CA1CA5ACA7CA5B | |
| SCHEMBL7643193 | 0.69 | CA12 (0.39) | CA2CA1CA5ACA7CA5B | |
| SCHEMBL6913710 | 0.65 | L3MBTL1 (0.37) | CA2CA1CA5ACA7CA5B | |
| SCHEMBL27455220 | 0.65 | MAPK8 (0.46) | STSCA2CA1CA5ACA7 | |
| SCHEMBL6909701 | 0.64 | ALDH1A1 (0.44) | CA2CA1SMN1; SMN2CA12CA9 | |
| SCHEMBL6167928 | 0.61 | CA9 (0.57) | STSCA2CA1CA5ACA7 | |
| SCHEMBL6421620 | 0.61 | MAPK8 (0.48) | STSCA2CA1CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2001446-A2 | FORMULATIONS OF SITAXSENTAN SODIUM | ENCYSIVE PHARMACEUTICALS, INC (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1996582-A2 | POLYMORPHS OF N-(4-CHLORO-3-METHYL-5-ISOXAZOLYL)2-Ý2-METHYL-4,5-(METHYLENEDIOXY) PHENYLACETYL¨THIOPHENE-3-SULFONAMIDE, SODIUM SALT | ENCYSIVE PHARMACEUTICALS, INC (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007106468-A2 | FORMULATIONS OF SITAXSENTAN SODIUM | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| WO-2007106467-A2 | POLYMORPHS OF N-(4-CHLORO-3-METHYL-5-ISOXAZOLYL)2-[2-METHYL-4,5-(METHYLENEDIOXY) PHENYLACETYL]THIOPHENE-3-SULFONAMIDE, SODIUM SALT | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| US-6432994-B1 | CARDIOVASCULAR DISORDERS, GLAUCOMA; ANTIINFLAMMATORY, WOUND HEALING, HYPOTENSIVE, ANTIASTHMATIC, AND ANTIANAPHYLACTIC AGENTS | TEXAS BIOTECHNOLOGY CORPORATION | 2002-08-13 | — | — | US | disclosed |
| EP-0819125-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-01-21 | — | — | EP | disclosed |
| WO-1996031492-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-10-10 | — | — | WO | disclosed |